Cas No.: 847058-45-1
PRODUCT INFORMATION
Description
CREKA is a tumor-homing pentapeptide (Cys-Arg-Glu-Lys-Ala) that specifically binds to fibrin-fibronectin complexes, which are often found in tumor vasculature models. Its terminal cysteine enables thiol-mediated bioconjugation to nanostructured carriers, such as gold nanoparticles. This conjugation has been shown to enhance accumulation in certain in vivo models, making it a useful tool for directed nanoparticle research.
Molecular Weight
605.71
Purity
> 95%
Formula
C₂₃H₄₃N₉O₈S
Product Type
Targeting Peptide
Sequence
Cys-Arg-Glu-Lys-Ala
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- NGR Peptide TFA (CAT#: OLY-1025-YS-59)
- Cyclo(RGDyK) TFA Targeting Peptide (CAT#: OLY-1025-YS-54)
- WLSEAGPVVTVRALRGTGSW TFA Targeting Peptide (CAT#: OLY-1025-YS-67)
- LSD Targeting Peptide (CAT#: OLY-1025-YS-2)
- Cys-SP94 Targeting Peptide (CAT#: OLY-1025-YS-35)
- GPC3 Targeting Peptide 1 (CAT#: OLY-1025-YS-37)
- IETP2 Targeting Peptide (CAT#: OLY-1025-YS-30)
- Cyclic SSTR Agonist Octreotide (CAT#: OLY-1025-YS-39)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.